Clinical Trial Update: The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes [NA]

View source ↗

Summary

The trial evaluated whether glucose-dependent insulinotropic polypeptide (GIP) modulates alpha cell response to hypoglycemia in people with type 1 diabetes; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• glucose-dependent insulinotropic polypeptide (GIP) (glucose-dependent insulinotropic polypeptide)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type1diabetes, Hypoglycemia | NA | Status: COMPLETED